TLR7 and neoplasm: We were particularly interested in the monocytes’ response to the TLR7/8 agonist since TLR7/8 has been shown to increase tumor cell proliferation in human PDAC and a TLR7/8 agonist has been shown to prolong survival in a PDAC mouse model (11–13).